ArticleNature machine intelligence2025
Tailored structured peptide design with a key-cutting machine approach.
Article in Nature machine intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational protein and peptide design is emerging as a transformative framework for engineering macromolecules with precise structures and functions, offering innovative solutions in medicine, biotechnology and materials science. However, current methods predominantly rely on generative models, which are expensive to train and modify. Here, we introduce the Key-Cutting Machine (KCM), an optimization-based platform that iteratively leverages structure prediction to match desired backbone geometries. KCM requires only a single graphics processing unit and enables seamless incorporation of user-defined requirements into the objective function, circumventing the high retraining costs typical of generative models while allowing straightforward assessment of measurable properties. By employing an estimation of distribution algorithm, KCM optimizes sequences on the basis of geometric, physicochemical and energetic criteria. We benchmarked its performance on α-helices, β-sheets, a combination of both and unstructured regions, demonstrating precise backbone geometry design. As a proof of concept, we applied KCM to antimicrobial peptide design by using a template antimicrobial peptide as the 'key', yielding a candidate with potent in vitro activity against multiple bacterial strains and efficacy in a murine infection model. KCM thus emerges as a robust tool for de novo protein and peptide design, offering a flexible paradigm for replicating and extending the structure-function relationships of existing templates.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.